Pentoxifylline as a Potential Adjuvant Therapy for COVID-19: Impeding the Burden of the Cytokine Storm

The outburst of inflammatory response and hypercoagulability are among the factors contributing to increased mortality in severe COVID-19 cases. Pentoxifylline (PTX), a xanthine-derived drug registered for the treatment of vascular claudication, has been reported to display broad-spectrum anti-infla...

Descripción completa

Detalles Bibliográficos
Autores principales: Feret, Wiktoria, Nalewajska, Magdalena, Wojczyński, Łukasz, Witkiewicz, Wojciech, Kłos, Patrycja, Dziedziejko, Violetta, Pawlik, Andrzej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8617922/
https://www.ncbi.nlm.nih.gov/pubmed/34830588
http://dx.doi.org/10.3390/jcm10225305

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8617922/
https://www.ncbi.nlm.nih.gov/pubmed/34830588
http://dx.doi.org/10.3390/jcm10225305

Ejemplares similares